Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
NATIONAL ELEC H (00213)
- 0.395
- 0.0000.00%
Not Open May 6 09:00 CST
360.51MMarket Cap3.76P/E (TTM)
0.000High0.000Low0Volume0.395Open0.395Prev Close0.00Turnover0.00%Turnover Ratio3.83P/E (Static)912.68MShares0.47052wk High0.14P/B360.51MFloat Cap0.33052wk Low0.01Dividend TTM912.68MShs Float1.085Historical High0.005Dividend LFY0.00%Range %-0.594Historical Low--Avg Price2000Lot Size1.27%Div Yield TTM1.27%Div Yield LFY
NATIONAL ELEC H (00213) Cash Flow
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 75.02%73.93M | ---- | -35.50%42.24M | ---- | -22.09%65.5M | ---- | -6.13%84.07M | ---- | -27.62%89.56M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 15.68%-15.12M | ---- | -43.68%-17.94M | ---- | -222.66%-12.48M | ---- | 26.96%-3.87M | ---- | 57.88%-5.3M |
| Attributable subsidiary (profit) loss | ---- | 64.90%30.69M | ---- | 74.34%18.61M | ---- | 111.02%10.68M | ---- | -816.78%-96.86M | ---- | 118.41%13.51M |
| Impairment and provisions: | ---- | 658.99%722.43K | ---- | 120.84%95.18K | ---- | -130.32%-456.65K | ---- | 122.99%1.51M | ---- | -2,116.95%-6.55M |
| -Impairmen of inventory (reversal) | ---- | 180.78%477.55K | ---- | -16.51%-591.18K | ---- | -134.35%-507.42K | ---- | 122.43%1.48M | ---- | -3,035.48%-6.59M |
| -Other impairments and provisions | ---- | -64.32%244.88K | ---- | 1,252.06%686.36K | ---- | 75.22%50.76K | ---- | -15.77%28.97K | ---- | -10.58%34.4K |
| Revaluation surplus: | ---- | 5.14%-210.69M | ---- | 16.50%-222.1M | ---- | -213.61%-265.99M | ---- | -0.78%-84.81M | ---- | 47.07%-84.16M |
| -Fair value of investment properties (increase) | ---- | 7.24%-207.13M | ---- | 25.24%-223.3M | ---- | -121.66%-298.7M | ---- | -49.81%-134.76M | ---- | 35.21%-89.95M |
| -Derivative financial instruments fair value (increase) | ---- | 39.18%-168.89K | ---- | -259.29%-277.69K | ---- | -282.91%-77.29K | ---- | -97.10%42.25K | ---- | 52.30%1.45M |
| -Other fair value changes | ---- | -329.56%-3.39M | ---- | -95.49%1.48M | ---- | -34.30%32.79M | ---- | 1,050.83%49.9M | ---- | 120.51%4.34M |
| Asset sale loss (gain): | ---- | -159.18%-41.34M | ---- | -614.22%-15.95M | ---- | -487.19%-2.23M | ---- | -44.49%-380.29K | ---- | 99.05%-263.2K |
| -Loss (gain) from sale of subsidiary company | ---- | 105.86%709.26K | ---- | ---12.1M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -878.10%-37.64M | ---- | -72.35%-3.85M | ---- | -487.19%-2.23M | ---- | -44.49%-380.29K | ---- | 98.70%-263.2K |
| -Loss (gain) from selling other assets | ---- | ---4.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -26.65%18.3M | ---- | -21.21%24.95M | ---- | -8.54%31.67M | ---- | -16.83%34.63M | ---- | -8.62%41.63M |
| -Depreciation | ---- | -2.43%6.06M | ---- | -22.24%6.21M | ---- | -18.70%7.99M | ---- | -26.09%9.83M | ---- | -19.57%13.3M |
| Financial expense | ---- | -5.13%202.35M | ---- | 52.07%213.3M | ---- | 87.39%140.27M | ---- | -5.19%74.85M | ---- | -31.56%78.95M |
| Special items | ---- | 96.72%-77.69K | ---- | -105.92%-2.37M | ---- | --40M | ---- | ---- | ---- | ---100.81K |
| Operating profit before the change of operating capital | ---- | 43.88%58.77M | ---- | 487.98%40.85M | ---- | -23.96%6.95M | ---- | -92.82%9.14M | ---- | 946.67%127.29M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -105.74%-3.18M | ---- | 68.17%55.33M | ---- | 647.95%32.9M | ---- | -108.91%-6M | ---- | 461.98%67.43M |
| Developing property (increase)decrease | ---- | -10.09%-505.09M | ---- | -19.48%-458.78M | ---- | 24.93%-383.97M | ---- | -207.39%-511.49M | ---- | 233.27%476.28M |
| Accounts receivable (increase)decrease | ---- | -595.76%-161.18M | ---- | -82.83%32.51M | ---- | 352.53%189.37M | ---- | 33.70%-74.99M | ---- | -581.26%-113.11M |
| Accounts payable increase (decrease) | ---- | -10.44%41.36M | ---- | 71.79%46.18M | ---- | 30.31%26.88M | ---- | 459.22%20.63M | ---- | 86.41%-5.74M |
| Advance payment increase (decrease) | ---- | 2,702.26%168.52M | ---- | -76.80%6.01M | ---- | -85.88%25.93M | ---- | 41.44%183.58M | ---- | 154.50%129.79M |
| Financial assets at fair value (increase)decrease | ---- | -107.33%-4.25M | ---- | 303.52%57.91M | ---- | 164.05%14.35M | ---- | -172.94%-22.41M | ---- | 66.08%-8.21M |
| Special items for working capital changes | ---- | 89.00%-6.4K | ---- | 79.39%-58.22K | ---- | 53.02%-282.54K | ---- | -210.88%-601.45K | ---- | -2.55%-193.47K |
| Cash from business operations | ---- | -84.08%-405.04M | ---- | -150.40%-220.04M | ---- | 78.15%-87.87M | ---- | -159.71%-402.14M | ---- | 270.05%673.53M |
| Hong Kong profits tax paid | ---- | -114.03%-3M | ---- | -2,720.76%-1.4M | ---- | 109.68%53.45K | ---- | -1,040.35%-552.26K | ---- | -86.41%58.73K |
| Other taxs | ---- | 320.89%2.66M | ---- | -29.06%632.89K | ---- | 106.07%892.16K | ---- | 64.42%-14.7M | ---- | -14,190.63%-41.3M |
| Special items of business | 152.80%95.19M | ---- | 16.62%-180.28M | ---- | -289.70%-216.21M | ---- | 143.34%113.97M | ---- | -78.43%-263M | ---- |
| Net cash from operations | 152.80%95.19M | -83.59%-405.37M | 16.62%-180.28M | -154.01%-220.81M | -289.70%-216.21M | 79.17%-86.93M | 143.34%113.97M | -166.01%-417.39M | -78.43%-263M | 259.93%632.29M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -15.68%15.12M | ---- | 45.78%17.94M | ---- | 226.38%12.3M | ---- | -27.53%3.77M | ---- | -58.31%5.2M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --129.5M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 330.42%183.72M | ---- | -165.72%-79.73M |
| Sale of fixed assets | ---- | 969.11%42.39M | ---- | 61.52%3.97M | ---- | 442.36%2.45M | ---- | 61.13%452.62K | ---- | -99.40%280.9K |
| Purchase of fixed assets | ---- | -20.60%-10.26M | ---- | -428.25%-8.51M | ---- | -32.21%-1.61M | ---- | 77.20%-1.22M | ---- | 20.67%-5.34M |
| Sale of subsidiaries | ---- | -85.32%40.13M | ---- | --273.36M | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.01%-132.56M | ---- | ---169.96M |
| Recovery of cash from investments | ---- | --24.79M | ---- | ---- | ---- | --3.32M | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 53.27%-79.91M | ---- | -6.97%-171.01M | ---- | -33.16%-159.86M | ---- | 15.48%-120.05M | ---- | -63.74%-142.03M |
| Other items in the investment business | 76.57%-12.44M | ---- | -6.31%-53.08M | ---- | 49.65%-49.92M | ---- | -948.62%-99.15M | ---- | 95.14%-9.46M | ---- |
| Net cash from investment operations | 76.57%-12.44M | -72.12%32.27M | -6.31%-53.08M | 180.72%115.75M | 49.65%-49.92M | -325.38%-143.39M | -948.62%-99.15M | 116.25%63.62M | 95.14%-9.46M | -154.34%-391.58M |
| Net cash before financing | 135.46%82.76M | -255.14%-373.1M | 12.31%-233.36M | 54.39%-105.06M | -1,895.14%-266.13M | 34.90%-230.32M | 105.44%14.83M | -246.97%-353.77M | 20.36%-272.45M | -26.01%240.71M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -20.59%2.06B | ---- | 17.04%2.6B | ---- | -8.16%2.22B | ---- | 106.56%2.41B | ---- | 71.08%1.17B |
| Refund | ---- | 49.01%-1.28B | ---- | -27.56%-2.51B | ---- | -4.31%-1.97B | ---- | -62.26%-1.89B | ---- | -139.10%-1.16B |
| Interest paid - financing | ---- | -0.91%-327.25M | ---- | -61.66%-324.31M | ---- | -88.11%-200.62M | ---- | 3.72%-106.65M | ---- | 30.66%-110.78M |
| Dividends paid - financing | ---- | 33.55%-10.99M | ---- | 49.67%-16.54M | ---- | 2.97%-32.86M | ---- | 2.06%-33.86M | ---- | 24.08%-34.58M |
| Issuance expenses and redemption of securities expenses | ---- | 91.80%-234.99K | ---- | 90.53%-2.87M | ---- | -39.55%-30.27M | ---- | 24.62%-21.69M | ---- | -35.13%-28.78M |
| Other items of the financing business | -173.37%-199.22M | 1,019.01%649.01K | 662.68%271.52M | 2.46%58K | 60.19%-48.25M | 102.56%56.6K | -161.09%-121.22M | -21.55%-2.21M | -55.76%198.44M | -107.51%-1.82M |
| Net cash from financing operations | -173.37%-199.22M | 258.65%437.45M | 662.68%271.52M | -738.84%-275.74M | 60.19%-48.25M | -109.54%-32.87M | -161.09%-121.22M | 279.57%344.47M | -55.76%198.44M | -574.72%-191.83M |
| Effect of rate | 67.11%-2.31M | -250.30%-5.28M | -514.33%-7.03M | -77.03%3.52M | 101.88%1.7M | 5.93%15.3M | -4,170.64%-90.32M | 133.15%14.44M | -112.84%-2.12M | -130.05%-43.57M |
| Net Cash | -405.19%-116.46M | 116.90%64.35M | 112.14%38.16M | -44.68%-380.79M | -195.50%-314.38M | -2,730.49%-263.19M | -43.75%-106.39M | -119.02%-9.3M | -169.50%-74.01M | -83.54%48.88M |
| Begining period cash | 12.43%534.09M | -44.27%475.03M | -44.27%475.03M | -22.53%852.3M | -22.53%852.31M | 0.47%1.1B | 0.47%1.1B | 0.49%1.1B | 0.49%1.1B | 34.24%1.09B |
| Cash at the end | -17.95%415.32M | 12.43%534.09M | -6.20%506.16M | -44.27%475.03M | -40.27%539.62M | -22.53%852.3M | -11.33%903.48M | 0.47%1.1B | -15.98%1.02B | 0.49%1.1B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.02B | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"